by Sowmya Viswanathan | Mar 12, 2018
Dr. Sheng Lin-Gibson is the Chief of Biosystems and Biomaterials Division at the U.S. National Institute of Standards and Technology (NIST) and directs its Regenerative Medicine Programs. She serves as the Convenor of ISO/TC 276: Biotechnology Working Group...
by Stacey Johnson | Mar 8, 2018
International Women’s Day (IWD), also known as the United Nations (UN) Day for Women’s Rights and International Peace, is an opportunity to honour women’s achievements, “to call for change and to celebrate acts of courage and determination by ordinary women who have...
by Stacey Johnson | Mar 6, 2018
Trustees at the Halton Catholic District School Board adopted a motion last week to ban board donations to non-profits or charities that publicly support “either directly or indirectly, abortion, contraception, sterilization, euthanasia, or embryonic stem cell...
by Patrick Bedford | Feb 26, 2018
Regenerative medicine researchers are making enormous strides to discover more about diseases and disease treatments. From heart regeneration to cancer immunotherapies to gene therapies, they are doing some of the most exciting research today, and some of them are...
by Stacey Johnson | Feb 23, 2018
If you follow amyotrophic lateral sclerosis (ALS) research, you may be interested to know that ALS Canada is holding a free webinar (registration link enclosed) on February 28 to explain how funds from the ALS #Icebucketchallenge from 2014 were spent. Do you remember...
by Samantha Payne | Feb 16, 2018
In many regenerative medicine strategies, we know that one strategy is usually not enough. Stimulating regeneration in any tissue is a complex, multifaceted problem involving the coordination of many biological signals. Yet what if we could deliver a therapeutic, like...
by David Kent | Feb 6, 2018
In my last post, I drew our readers’ attention to an excellent article by Giulio Cossu and colleagues on stem cells and regenerative medicine where the authors set out a number of recommendations for the regenerative medicine field. One of those recommendations was...
by Stacey Johnson | Feb 2, 2018
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event...
by David Kent | Jan 22, 2018
Over the Christmas break, I finally got around to reading an article that has been in my “to read” pile for far too long. For anybody new to the regenerative medicine and cellular therapy fields, it is an absolutely fantastic resource to catch up on some of the...
by Sara M. Nolte | Jan 15, 2018
With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...
Comments